Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Huntington Ingalls Industries Inc (HII) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance

Huntington Ingalls Industries IncTrade
Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Huntington Ingalls Industries Inc vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Huntington Ingalls Industries Inc trades at $265.14 (market cap $10.16B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Huntington Ingalls Industries Inc is far larger — about 2.4× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Huntington Ingalls Industries Inc pays a 2.14% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Huntington Ingalls Industries Inc for 30 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.

HIIINDV
Market Cap
$10.16B$4.18B
Volume
503,0291,819,746
Sector
IndustrialsHealth
52-Week High
$453.73$41.83
52-Week Low
$257.05$24.09
Typical Hold Time
30 Days0 Days
Enterprise Value
$13.08B$4.47B
Dividend Yield
2.14%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Huntington Ingalls Industries Inc

HII trades at $257.84, down 2.34% today, amid a bearish technical signal but strong fundamentals. The company demonstrates consistent earnings beats, with Q2 2026 EPS of $5.27 exceeding expectations by 39%. Recent contract wins, including a $5.1 billion aircraft carrier overhaul and 10 unmanned vessel orders, bolster its $57.3 billion backlog. Valuation metrics appear attractive with a P/E of 15.36 and P/S of 0.77.

The investment case balances strong defense sector positioning against near-term technical weakness. Analyst consensus targets $357.00, implying 38% upside, with 41% buy ratings. Key risks include execution on large contracts and defense budget fluctuations. The current price near support at $258 presents a potential entry point for long-term investors.

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HII

No sentiment data available yet.

INDV
100% Buy0% Sell
Avg holding period · 0 Days

About Huntington Ingalls Industries Inc

Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.

Read more on HII →

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →